WebAug 8, 2013 · Impax Laboratories ( IPXL) has been making news quite regularly in recent weeks thanks to its run-ins with the FDA and its tie-ups with other pharma behemoths to sell generic drugs. It has... WebApr 26, 2024 · Impax Laboratories, Inc. (IPXL) Quote Overview » News » Impax Laboratories, Inc. (IPXL) Zacks News . Trades from $ 1. Zacks News. New Strong Sell Stocks for April …
IPXL
WebAMSTERDAM, Sept. 25, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency... WebDec 20, 2016 · HAYWARD, Calif., Dec. 20, 2016 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that J. Kevin Buchi, a member of the Impax Board of … diary of poppy
Impax Laboratories Inc. (IPXL) in Focus: Stock Rises 11.8% - Yahoo
WebView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas … WebImpax Labs Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Impax Labs Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Trade IPXL with: Price/Earnings ttm 29.05 ; Earnings Per Share ttm 0.63 ; Most ... WebJan 30, 2008 · HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL - News) today announced that it has received a non-approvable letter from the U.S. Food and Drug Administration (FDA) concerning its new drug application (NDA) and subsequent submissions for Vadova® (carbidopa/levodopa extended release) tablets. cities starting with the letter a